New trends in patient management: risk-based therapy for febrile patients with neutropenia.
about
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsOral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsManagement of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French SInfections in Cancer Patients with Solid Tumors: A Review.Febrile neutropenia in French emergency departments: results of a prospective multicentre survey2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.Ceftriaxone in febrile neutropenia.Empiric therapy for febrile neutropenia: what are the choices?Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcomaComparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer.A Comparative Study of Piperacillin-Tazobactam With and Without Vancomycin as Empirical Therapy for Febrile Neutropenic Patients With Solid Tumor Malignancies.Effects of indirect and additional direct costs on the risk threshold for prophylaxis with colony-stimulating factors in patients at risk for severe neutropenia from cancer chemotherapy.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
P2860
Q24197538-0E824355-DC06-497A-953D-DDA86AA8535FQ24246096-B004E970-4AB0-4092-BE20-7339E1087CF3Q27320711-E4D327AC-1309-4CD6-8651-DFF09AFDCB79Q30238576-A860DA4A-35D0-4113-ABB7-E69D8EA2594EQ33919284-40F56159-1FE7-4062-BB31-1C41AA27F244Q34114674-EEB3DDBA-9A8D-41AD-A396-F2158186313CQ34448617-EA79D9AC-6862-4C5E-9271-4373EECB5D2DQ35117960-367980EB-EDFF-4ABC-B323-F8D5A8CDEAB5Q35179915-F60022F3-921F-4E7C-AC30-F2F78811BD00Q36839750-104B2561-6D76-4154-88B7-10308873D63AQ36918707-357DCB62-24C9-4EAC-A243-2B338954D3B9Q40441842-75622F76-EE0F-4D54-8156-B016071943DAQ40593575-F736FF80-E7F0-41CB-9413-6FD1867609D3Q44904363-047AADA7-64FD-455B-BBBC-F5EAAD5D6BC1Q45305512-DE7ACC83-1A2B-4083-93DC-DF56509CFB5DQ47731362-D46F2E9F-7E92-427E-B837-F477C1457D91Q51617424-F02ABA8A-82B4-4BE8-8AB2-7367B38C509E
P2860
New trends in patient management: risk-based therapy for febrile patients with neutropenia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New trends in patient manageme ...... ile patients with neutropenia.
@ast
New trends in patient manageme ...... ile patients with neutropenia.
@en
type
label
New trends in patient manageme ...... ile patients with neutropenia.
@ast
New trends in patient manageme ...... ile patients with neutropenia.
@en
prefLabel
New trends in patient manageme ...... ile patients with neutropenia.
@ast
New trends in patient manageme ...... ile patients with neutropenia.
@en
P356
P1476
New trends in patient manageme ...... ile patients with neutropenia.
@en
P2093
Rolston KV
P304
P356
10.1086/598624
P407
P577
1999-09-01T00:00:00Z